AbbVie to Host Virtual Immunology Strategic Update
AbbVie will conduct a virtual immunology strategic update for investors on December 14, 2020, at 9:00 a.m. Central time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie will conduct a virtual immunology strategic update for investors on December 14, 2020, at 9:00 a.m. Central time. Richard A. Gonzalez, CEO, alongside the executive leadership team, will discuss AbbVie's immunology business and pipeline. Investors can access a live audio webcast on AbbVie's Investor Relations site, with an archived version available later that day. AbbVie's mission focuses on developing innovative medicines across various therapeutic areas, including immunology, oncology, and more.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was -0.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH CHICAGO, Ill., Dec. 1, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time. Richard A. Gonzalez, chairman of the board and chief executive officer, and members of the executive leadership team will present on AbbVie's immunology business and pipeline.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the webcast will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-virtual-immunology-strategic-update-301181943.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.